These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons. Harasta AE; Ittner LM Adv Neurobiol; 2017; 15():3-29. PubMed ID: 28674976 [TBL] [Abstract][Full Text] [Related]
5. Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development? Duff K; Suleman F Brief Funct Genomic Proteomic; 2004 Apr; 3(1):47-59. PubMed ID: 15163359 [TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse models of Alzheimer's disease. Elder GA; Gama Sosa MA; De Gasperi R Mt Sinai J Med; 2010; 77(1):69-81. PubMed ID: 20101721 [TBL] [Abstract][Full Text] [Related]
7. An Alzheimer's mouse at last? Altman J Mol Med Today; 1995 Apr; 1(1):1. PubMed ID: 9415125 [No Abstract] [Full Text] [Related]
12. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease. Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117 [TBL] [Abstract][Full Text] [Related]
13. [Development of transgenic animal models for Alzheimer's disease]. Watanabe N; Tabira T No To Shinkei; 2001 Sep; 53(9):809-20. PubMed ID: 11596475 [No Abstract] [Full Text] [Related]
14. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice. Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827 [TBL] [Abstract][Full Text] [Related]
15. New hopes arise with the transgenic model for Alzheimer's disease. Kotula L; Wisniewski HM Neurobiol Aging; 1995; 16(4):701-3. PubMed ID: 8544922 [No Abstract] [Full Text] [Related]
17. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]
18. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100 [TBL] [Abstract][Full Text] [Related]
19. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw). Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517 [TBL] [Abstract][Full Text] [Related]